NSE: INFY | BSE: 500209

Mid-range Performer

Download real time

1519.00 5.30 (0.35%)

5.9M NSE+BSE Volume

NSE 30 Jul, 2025 3:31 PM (IST)

631,034

Market Cap

Market Runner Up

1.1

Beta 1Year

High Volatility

Infosys Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for INFY, BSE:500209 Infosys Ltd.

Infosys Ltd.

24 Oct 2017

1519.00

0.35%

Infosys: Holding fort; no red alarms post CEO exit

Buy: Infosys Ltd.

Target

Motilal Oswal

(implies 1% CQGR at the midpoint for 2H). We read this as a function of: [1] lower 2Q growth than that seen historically, even in subdued years and [2] conservatism that has characterized the founders' approach in the past....

Prabhudas Lilladhar downgraded Infosys Ltd. to Accumulate with a price target of 1750.0 on 24 Jul, 2025.

Infosys Ltd.

29 Sep 2017

1519.00

0.35%

Light House - A Quick Perspective -Infosys Ltd. - 29 September 2017

Buy: Infosys Ltd.

Way2Wealth

Infosys is the secondlargest IT services company in India providing consulting and IT Services globally. As one of the fastest growing IT services company globally it is a leader in the offshore services space. Infosys provides business consulting, application development and maintenance and engineering services to 1,164 active clients spread across Banking, Financial Services, Insurance, Retail, Manufacturing, and Utilities verticals and 50 countries. The company has also its own proprietary core banking software Finacle used by some of the...

Prabhudas Lilladhar downgraded Infosys Ltd. to Accumulate with a price target of 1750.0 on 24 Jul, 2025.

Infosys Ltd.

13 Sep 2017

1519.00

0.35%

Infosys Ltd.- Buyback

Daily Note: Infosys Ltd.

AUM Capital

Infosys is a global leader in technology services and consulting. It enables clients in 45 countries to create and execute strategies for their digital transformation. From engineering to application development, knowledge management and business process management, the company helps its clients find the right problems to solve, and to solve them effectively. The team of 198,000+ innovators, across the globe, is differentiated by the imagination, knowledge and...

Infosys Ltd. is trading below all available SMAs

Infosys Ltd.

28 Aug 2017

1519.00

0.35%

Company Update of Infosys

Accumulate: Infosys Ltd.

Target

IDBI Capital

We believe that Mr Nadan Nilekani joining Infosys (INFO) board as non-executive Chairman on Thursday is a great move amid Dr. Vishal Sikka's stepping down as MD & CEO just a week earlier. We did not expect such a move to happen so fast. At the investor con-call, Mr Nilekani clearly mentioned that his top priority is to make INFO the enterprise of future and restore the company on the growth path with consensus of all stakeholders. We believe that the worst is over for INFO and upgrade it to ACCUMULATE from HOLD with new TP of Rs988 based on 14x FY19E (13x earlier) and factor the impact...

Infosys Ltd. has an average target of 1702.00 from 11 brokers.

Infosys Ltd.

23 Aug 2017

1519.00

0.35%

Flash Note - Infosys

Hold: Infosys Ltd.

Recommendation Target

Axis Direct

Infosys had featured as our top buy in the IT space due to (1) great leadership and their ability to scale the company towards next-gen services and (2) reasonable valuations. However, Dr. Vishal Sikka's resignation has clearly surprised us and has not gone down well with investors.

Infosys Ltd. has an average target of 1702.00 from 11 brokers.

Infosys Ltd.

20 Aug 2017

1519.00

0.35%

Infosys (Update): Back to the (drawing) board. Downgrade to NEUTRAL

Neutral: Infosys Ltd.

Recommendation Target

HDFC Securities

Downgrade to NEUTRAL with a TP of Rs 995, 14x FY19E EPS. Our multiple is reduced to reflect the twin perils of internal corporate battles and a challenging business environment that the company will now have to navigate. Fridays dramatic events starting with the resignation of Vishal Sikka, followed by the unseemly public spat between the Infosys board and its founders pose collateral risks for the firm at just the wrong time. After three grating years, Sikka had barely got Infosys looking sharper and smarter. In our view it is the Board which is saddled with eroded credibility, as it has defended Sikka against founders allegations but has been unable to retain him. We think the founders are not done and expect an extended battle for credibility.

Infosys Ltd. is trading below all available SMAs

Infosys Ltd.

18 Aug 2017

1519.00

0.35%

Infosys Ltd

Hold: Infosys Ltd.

Target

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Infosys' Vishal Sikka has resigned from his position as MD & CEO. He has been appointed the Executive Vice-Chairman. COO UB Pravin Rao has been appointed the interim-MD and CEO. We would be closely watching the company's revenues growth guidance of 6.5-8.5% (in constant currency terms) for FY18E in the midst of recent developments. We maintain our HOLD rating on the stock with a revised target price of | 975. We also advise investors not to accumulate fresh position in the stock...

Infosys Ltd. has an average target of 1702.00 from 11 brokers.

Infosys Ltd.

18 Aug 2017

1519.00

0.35%

Company Update review of Infosys

Hold: Infosys Ltd.

Recommendation Target

IDBI Capital

Infosys's (INFO) MD & CEO, Dr Vishal Sikka, has decided to exit. We believe that this is negative for INFO at a time when it is gearing up to get back to industry-leading growth amid sector's transition to new technologies. In his e-mail to the board of directors, Dr Sikka mentioned that addressing to personal accusations took away significant part of his bandwidth. The board of directors also mentioned the same reason for Dr Sikka's exit in a press release. We hope that the new MD & CEO does not have to face the same. We cut our FY18/19 revenue forecast by 1.1%/3.6% and EPS forecast by 2.8%/8.8%....

Infosys Ltd. has an average target of 1702.00 from 11 brokers.

Is Infosys Ltd. worth buying?

4098 Votes:

Buy 75.92%

Sell 11.37%

Hold 12.71%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf